NCT06998017

Brief Summary

The objective of this study is to explore the safety and feasibility of conducting low-volume, high-intensity interval training (HIIT) on a total body recumbent stepper (TBRS) in persons with stroke in an inpatient rehabilitation setting.

Trial Health

65
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
15

participants targeted

Target at below P25 for early_phase_1 stroke

Timeline
3mo left

Started Apr 2026

Shorter than P25 for early_phase_1 stroke

Status
not yet recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress22%
Apr 2026Aug 2026

First Submitted

Initial submission to the registry

March 5, 2025

Completed
3 months until next milestone

First Posted

Study publicly available on registry

May 31, 2025

Completed
11 months until next milestone

Study Start

First participant enrolled

April 13, 2026

Completed
3 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

July 1, 2026

Expected
1 month until next milestone

Study Completion

Last participant's last visit for all outcomes

August 1, 2026

Last Updated

April 15, 2026

Status Verified

April 1, 2026

Enrollment Period

3 months

First QC Date

March 5, 2025

Last Update Submit

April 10, 2026

Conditions

Outcome Measures

Primary Outcomes (4)

  • Safety of LVHIIT (low volume high intensity interval training) on total body recumbent stepper

    Treatment related adverse events will be defined as the presence of study-related cardiac or serious adverse events. The Investigators hypothesize that low-volume, short-interval, TBRS HIIT will have no incidents of treatment related adverse events in participants with subacute stroke while admitted to inpatient rehabilitation during HIIT (H1a) and within the 30 minutes following HIIT cessation (H1b).

    2-3 months

  • Adherence of LVHIIT (low volume high intensity interval training) on total body recumbent stepper

    Feasibility will be assessed by adherence to the exercise session, attainment of target heart rates, and acceptability of the exercise. Adherence will measured by ≥ 75% of participants complete the entire 10-minute HIIT bout (H2a). Units will be the number of participants that are able to finish the full 10 minute bout of exercise.

    2-3 months

  • Attainment of LVHIIT (low volume high intensity interval training) on total body recumbent stepper

    Feasibility will be assessed by adherence to the exercise session, attainment of target heart rates, and acceptability of the exercise. Attainment will be measured by ≥75% of participants will reach target heart rates (75%-85% max HR) during ≥75% of the high-intensity intervals (H2b). Heart rates will be measured in beats per minute. HR max will be calculated using an algorithm that adjusts for age, or beta blocker use. Units will be the number of participants reaching target HR.

    2-3 months

  • Acceptability of LVHIIT (low volume high intensity interval training) on total body recumbent stepper

    Feasibility will be assessed by adherence to the exercise session, attainment of target heart rates, and acceptability of the exercise. To examine acceptability, the valid and reliable 8-item Physical Activity Enjoyment Scale (PACES-8) will be used, where higher scores indicate greater exercise enjoyment (H2c).

    2-3 months

Study Arms (1)

Low-Volume High Intensity Interval Training

EXPERIMENTAL

This is the only arm in the study as it is a feasibility trial.

Other: Low Volume High Intensity Interval Training

Interventions

Participants will conduct aerobic exercise on a total body recumbent stepper to get their heart rates to levels consistent with high intensity exercise.

Low-Volume High Intensity Interval Training

Eligibility Criteria

Age18 Years - 85 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Both sexes between the age of 18-85 years at time of consent
  • Ischemic or hemorrhagic stroke at consent. People with stroke and newly diagnosed cardiovascular complications had \>50% prevalence of recurrent stroke at 5 years. Index stroke or recurrent stroke on same side as index stroke will be allowed.
  • Exercise continuously for minimum of 30 watts for 3 minutes on the recumbent stepper to demonstrate ability to perform the exercise test or therapist confirmation/documentation of participant's ability to use the recumbent stepper.
  • No aerobic exercise contraindications or other safety/physical concerns during the submaximal exercise test determined by the therapy team or inpatient physicians.
  • Able to communicate with investigators, follow 2-step command \& correctly answer consent comprehension questions

You may not qualify if:

  • Implanted pacemaker or defibrillator limiting exercise performance
  • Reported pain that limits or interferes with activities of daily living and physical activity/exercise
  • Acute Myocardial Infarction in the last 2 days
  • Ongoing unstable Angina
  • Active Endocarditis
  • Symptomatic Severe Aortic Stenosis
  • Decompensated Heart Failure
  • Acute Pulmonary Embolism, Pulmonary Insufficiency, or Deep Veinous Thrombosis
  • Acute Myocarditis or Pericarditis
  • Other significant neurologic, orthopedic, or peripheral vascular conditions that would limit exercise participation
  • Oxygen-dependent chronic obstructive pulmonary disease
  • Neurological disease (Multiple Sclerosis, Alzheimer's disease, Parkinson's disease)
  • Pregnancy

Contact the study team to confirm eligibility.

Sponsors & Collaborators

MeSH Terms

Conditions

Stroke

Condition Hierarchy (Ancestors)

Cerebrovascular DisordersBrain DiseasesCentral Nervous System DiseasesNervous System DiseasesVascular DiseasesCardiovascular Diseases

Study Officials

  • Alexandra Arickx, MD

    University of Kansas

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Ann Wingard, DO

CONTACT

Alexandra Arickx, MD

CONTACT

Study Design

Study Type
interventional
Phase
early phase 1
Allocation
NA
Masking
NONE
Purpose
OTHER
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

March 5, 2025

First Posted

May 31, 2025

Study Start

April 13, 2026

Primary Completion (Estimated)

July 1, 2026

Study Completion (Estimated)

August 1, 2026

Last Updated

April 15, 2026

Record last verified: 2026-04